Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 885

1.

Cellular therapy for acute myeloid Leukemia - Current status and future prospects.

Hansrivijit P, Gale RP, Barrett J, Ciurea SO.

Blood Rev. 2019 May 11. pii: S0268-960X(18)30123-1. doi: 10.1016/j.blre.2019.05.002. [Epub ahead of print] Review.

PMID:
31109711
2.

Post-transplant cyclophosphamide use in matched HLA donors: a review of literature and future application.

El Fakih R, Hashmi SK, Ciurea SO, Luznik L, Gale RP, Aljurf M.

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0547-8. [Epub ahead of print] Review.

PMID:
31089284
3.

Impact of T-cell dose on the outcome of T-cell replete HLA matched allogeneic peripheral blood stem cell transplantation.

Saad A, Lamb L, Wang T, Hemmer MT, Spellman S, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Agrawal V, Aljurf M, Beitinjaneh AM, Bhatt VR, Buchbinder D, Byrne M, Cahn JY, Cairo M, Castillo P, Chhabra S, Diaz MA, Farhan S, Floisand Y, Frangoul HA, Gadalla SM, Gajewski J, Gale RP, Gandhi M, Gergis U, Hamilton BK, Hematti P, Hildebrandt GC, Kamble RT, Kanate AS, Khandelwal P, Lazaryn A, MacMillan M, Marks DI, Martino R, Mehta PA, Nishihori T, Olsson RF, Patel SS, Qayed M, Rangarajan HG, Reshef R, Ringden O, Savani BN, Schouten HC, Schultz KR, Seo S, Shaffer BC, Solh M, Teshima T, Urbano-Ispizua A, Verdonck LF, Vij R, Waller EK, William B, Wirk B, Yared JA, Yu LC, Arora M, Hashmi S.

Biol Blood Marrow Transplant. 2019 May 11. pii: S1083-8791(19)30291-5. doi: 10.1016/j.bbmt.2019.05.007. [Epub ahead of print]

PMID:
31085303
4.

Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study.

Garweg JG, Stefanickova J, Hoyng C, Schmelter T, Niesen T, Sowade O, Sivaprasad S; AQUA Investigators.

Ophthalmol Retina. 2019 Mar 21. pii: S2468-6530(18)30366-X. doi: 10.1016/j.oret.2019.03.012. [Epub ahead of print]

PMID:
31080168
5.

Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second generation tyrosine kinase inhibitors.

Nteliopoulos G, Bazeos A, Claudiani S, Gerrard G, Curry E, Szydlo R, Alikian M, Foong HE, Nikolakopoulou Z, Loaiza S, Khorashad JS, Milojkovic D, Perrotti D, Gale RP, Foroni L, Apperley JF.

Haematologica. 2019 May 9. pii: haematol.2018.200220. doi: 10.3324/haematol.2018.200220. [Epub ahead of print]

6.

Prognostic mutations in persons with isolated neutropenia myelodysplastic syndrome.

Shi Z, Qin T, Xu Z, Li B, Huang H, Zhang H, Fang L, Pan L, Hu N, Qu S, Huang G, Gale RP, Xiao Z.

Leuk Lymphoma. 2019 May 6:1-3. doi: 10.1080/10428194.2019.1607324. [Epub ahead of print] No abstract available.

PMID:
31056995
7.

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Ahmed I, Aljurf M, Askar M, Auletta JJ, Bhatt V, Bredeson C, Chhabra S, Gadalla S, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Inamoto Y, Kitko C, Khandelwal P, MacMillan ML, Majhail N, Marks DI, Mehta P, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Qayed M, Rangarajan H, Ringden O, Saad A, Savani BN, Seo S, Shah A, Shah N, Schultz KR, Solh M, Spitzer T, Szer J, Teshima T, Verdonck LF, Williams KM, Wirk B, Wagner J, Yared JA, Weisdorf DJ.

Blood Adv. 2019 May 14;3(9):1441-1449. doi: 10.1182/bloodadvances.2018030171.

8.

Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia?

Saglio G, Fava C, Gale RP.

Haematologica. 2019 May;104(5):862-864. doi: 10.3324/haematol.2018.214445. No abstract available.

9.

CBeV (cyclophosphamide, bendamustine and etoposide) pre-autotransplant conditioning in persons with lymphoma.

Jaimovich G, Ostriz MBR, Castro M, Riera L, Foncuberta C, Longoni H, Cia A, Duarte P, Vitriu A, Lastiri F, Gale RP.

Bone Marrow Transplant. 2019 Apr 23. doi: 10.1038/s41409-019-0528-y. [Epub ahead of print] No abstract available.

PMID:
31015577
10.

Determine safety of outpatient chemotherapy and autotransplants using refrigerated, non-frozen grafts in persons with multiple sclerosis.

Gale RP, Gómez-Cruz GB, Olivares-Gazca JC, León-Peña AA, Gómez-Almaguer D, Gómez-De-León A, González-López EE, Ruiz-Argüelles A, Soto-Vega E, Muñoz-Pérez MJ, Ruiz-Delgado GJ, Ruiz-Argüelles GJ.

Clin Transplant. 2019 Apr 20:e13567. doi: 10.1111/ctr.13567. [Epub ahead of print]

PMID:
31004516
11.

Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service.

Gale RP, Mahmood S, Devonport H, Patel PJ, Ross AH, Walters G, Downey L, El-Sherbiny S, Freeman M, Berry S, Jain N.

Eye (Lond). 2019 Mar;33(Suppl 1):1-21. doi: 10.1038/s41433-018-0300-3. Review.

PMID:
30926932
12.

Causal inference in randomized clinical trials.

Zheng C, Dai R, Gale RP, Zhang MJ.

Bone Marrow Transplant. 2019 Mar 26. doi: 10.1038/s41409-018-0424-x. [Epub ahead of print] No abstract available.

PMID:
30914756
13.

Statistical analyses of clinical trials in haematopoietic cell transplantation or why there is a strong correlation between people drowning after falling out of a fishing boat and marriage rate in Kentucky.

Gale RP, Zhang MJ.

Bone Marrow Transplant. 2019 Mar 26. doi: 10.1038/s41409-019-0431-6. [Epub ahead of print] No abstract available.

PMID:
30914755
14.

Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant.

Parikh SH, Satwani P, Ahn KW, Sahr NA, Fretham C, Abraham AA, Agrawal V, Auletta JJ, Abdel-Azim H, Copelan E, Diaz MA, Dvorak CC, Frangoul HA, Freytes CO, Gadalla SM, Gale RP, George B, Gergis U, Hashmi S, Hematti P, Hildebrandt GC, Keating AK, Lazarus HM, Myers KC, Olsson RF, Prestidge T, Rotz SJ, Savani BN, Shereck EB, Williams KM, Wirk B, Pasquini MC, Loren AW.

JAMA Pediatr. 2019 Mar 18:e190081. doi: 10.1001/jamapediatrics.2019.0081. [Epub ahead of print]

PMID:
30882883
15.

Response to the Commentary on "Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma".

Barosi G, Gale RP.

Leukemia. 2019 May;33(5):1301-1302. doi: 10.1038/s41375-019-0432-x. Epub 2019 Mar 6. No abstract available.

PMID:
30842607
16.

Prognostic impact of red blood cell distribution width in myelodysplastic syndromes.

Shi Z, Li B, Huang H, Qin T, Xu Z, Zhang H, Fang L, Pan L, Hu N, Qu S, Huang G, Gale RP, Xiao Z.

Br J Haematol. 2019 Mar 5. doi: 10.1111/bjh.15830. [Epub ahead of print] No abstract available.

PMID:
30836422
17.

Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.

Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Al-Khinji A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N.

Bone Marrow Transplant. 2019 May;54(5):782-783. doi: 10.1038/s41409-019-0472-x.

PMID:
30809032
18.

Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades.

Kilari D, D'Souza A, Fraser R, Qayed M, Davila O, Agrawal V, Diaz MA, Chhabra S, Cerny J, Copelan E, Farhadfar N, Freytes CO, Gale RP, Ganguly S, Hildebrandt GC, Holmberg L, Kamble RT, Kapoor P, Lazarus H, Lee C, Murthy HS, Naik S, Nishihori T, Saad A, Savani BN, Seo S, Warwick A, Wirk B, Yared JA, Nieto Y, Hari P.

Biol Blood Marrow Transplant. 2019 Feb 20. pii: S1083-8791(19)30140-5. doi: 10.1016/j.bbmt.2019.02.015. [Epub ahead of print]

PMID:
30794931
19.

Chronic myeloid leukemia: Two mysteries.

Radivoyevitch T, Jorgensen TN, Lindner DJ, Maciejewski JP, Miyazaki Y, Gale RP.

Leuk Res. 2019 Apr;79:3-5. doi: 10.1016/j.leukres.2019.02.003. Epub 2019 Feb 12. No abstract available.

PMID:
30780032
20.

Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study.

Abidi MZ, Hari P, Chen M, Kim S, Battiwala M, Dahi PB, Diaz MA, Gale RP, Ganguly S, Gergis U, Green J, Hildebrandt G, Hill JA, Komanduri K, Lazarus H, Marks D, Nishihori T, Olsson R, Seo S, Ustun C, Yared J, Yin D, Wingard J, Wirk BM, Auletta J, Lindemans C, Riches M.

Bone Marrow Transplant. 2019 Jan 29. doi: 10.1038/s41409-019-0457-9. [Epub ahead of print]

PMID:
30696997
21.

Is lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma?

Barosi G, Gale RP.

Leukemia. 2019 Mar;33(3):588-596. doi: 10.1038/s41375-019-0383-2. Epub 2019 Jan 28. Review.

PMID:
30692596
22.

New study-designs to address the clinical complexity of acute myeloid leukemia.

Estey E, Othus M, Gale RP.

Leukemia. 2019 Mar;33(3):567-569. doi: 10.1038/s41375-018-0363-y. Epub 2019 Jan 22. No abstract available.

PMID:
30670784
23.

Prof. Franco Mandelli Leukaemia Visionary. May 12, 1931- July 15, 2018.

Amadori S, Arcese W, Avvisati G, Gale RP, Lo-Coco F.

Leukemia. 2019 Feb;33(2):285-286. doi: 10.1038/s41375-018-0352-1. No abstract available.

PMID:
30635628
24.

Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma.

Gopalakrishnan S, D'Souza A, Scott E, Fraser R, Davila O, Shah N, Gale RP, Kamble R, Diaz MA, Lazarus HM, Savani BN, Hildebrandt GC, Solh M, Freytes CO, Lee C, Kyle RA, Usmani SZ, Ganguly S, Assal A, Berdeja J, Kanate AS, Dhakal B, Meehan K, Kindwall-Keller T, Saad A, Locke F, Seo S, Nishihori T, Gergis U, Gasparetto C, Mark T, Nieto Y, Kumar S, Hari P.

Biol Blood Marrow Transplant. 2019 Apr;25(4):683-688. doi: 10.1016/j.bbmt.2018.12.141. Epub 2018 Dec 21.

PMID:
30579965
25.

Refining AML outcome prediction.

Hourigan CS, Gale RP, Walter RB.

Leukemia. 2019 Feb;33(2):283-284. doi: 10.1038/s41375-018-0317-4. Epub 2018 Dec 14. No abstract available.

PMID:
30552400
26.

Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.

Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Al-Khinji A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N.

Bone Marrow Transplant. 2019 May;54(5):648-661. doi: 10.1038/s41409-018-0339-6. Epub 2019 Feb 27. Review. Erratum in: Bone Marrow Transplant. 2019 Feb 27;:.

PMID:
30531955
27.

Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.

Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Ahmed A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hashmi S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N.

Biol Blood Marrow Transplant. 2019 May;25(5):e145-e154. doi: 10.1016/j.bbmt.2018.11.033. Epub 2018 Dec 3. Review.

PMID:
30521975
28.

Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.

Brunstein CG, Pasquini MC, Kim S, Fei M, Adekola K, Ahmed I, Aljurf M, Agrawal V, Auletta JJ, Battiwalla M, Bejanyan N, Bubalo J, Cerny J, Chee L, Ciurea SO, Freytes C, Gadalla SM, Gale RP, Ganguly S, Hashmi SK, Hematti P, Hildebrandt G, Holmberg LA, Lahoud OB, Landau H, Lazarus HM, de Lima M, Mathews V, Maziarz R, Nishihori T, Norkin M, Olsson R, Reshef R, Rotz S, Savani B, Schouten HC, Seo S, Wirk BM, Yared J, Mineishi S, Rogosheske J, Perales MA.

Biol Blood Marrow Transplant. 2019 Mar;25(3):480-487. doi: 10.1016/j.bbmt.2018.11.005. Epub 2018 Nov 10.

PMID:
30423481
29.

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.

Chhabra S, Ahn KW, Hu ZH, Jain S, Assal A, Cerny J, Copelan EA, Daly A, DeFilipp Z, Gadalla SM, Gale RP, Ganguly S, Hamilton BK, Hildebrandt GC, Hsu JW, Inamoto Y, Kanate AS, Khoury HJ, Lazarus HM, Litzow MR, Nathan S, Olsson RF, Pawarode A, Ringden O, Rowe JM, Saad A, Savani BN, Schouten HC, Seo S, Shah NN, Solh M, Stuart RK, Ustun C, Woolfrey AE, Yared JA, Alyea EP, Kalaycio ME, Popat U, Sobecks RM, Saber W.

Blood Adv. 2018 Nov 13;2(21):2922-2936. doi: 10.1182/bloodadvances.2018024844.

30.

Maintenance of human haematopoietic stem and progenitor cells in vitro using a chemical cocktail.

Jiang M, Chen H, Lai S, Wang R, Qiu Y, Ye F, Fei L, Sun H, Xu Y, Jiang X, Zhou Z, Zhang T, Li Y, Xie J, Fang Q, Gale RP, Han X, Huang H, Guo G.

Cell Discov. 2018 Oct 30;4:59. doi: 10.1038/s41421-018-0059-5. eCollection 2018.

31.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.

Alousi A, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Pidala J, Anderlini P, Boyiadzis M, Bredeson CN, Cahn JY, Cairo MS, Gadalla SM, Hashmi SK, Gale RP, Kanda J, Kamble RT, Kharfan-Dabaja MA, Litzow MR, Ringden O, Saad AA, Schultz KR, Verdonck LF, Waller EK, Yared JA, Holtan SG, Weisdorf DJ.

Biol Blood Marrow Transplant. 2019 Feb;25(2):270-278. doi: 10.1016/j.bbmt.2018.09.004. Epub 2018 Oct 3.

PMID:
30292009
32.

Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.

Norkin M, Shaw BE, Brazauskas R, Tecca HR, Leather HL, Gea-Banacloche J, T Kamble R, DeFilipp Z, Jacobsohn DA, Ringden O, Inamoto Y, A Kasow K, Buchbinder D, Shaw P, Hematti P, Schears R, Badawy SM, Lazarus HM, Bhatt N, Horn B, Chhabra S, M Page K, Hamilton B, Hildebrandt GC, Yared JA, Agrawal V, M Beitinjaneh A, Majhail N, Kindwall-Keller T, Olsson RF, Schoemans H, Gale RP, Ganguly S, A Ahmed I, Schouten HC, L Liesveld J, Khera N, Steinberg A, Shah AJ, Solh M, Marks DI, Rybka W, Aljurf M, Dietz AC, Gergis U, George B, Seo S, Flowers MED, Battiwalla M, Savani BN, Riches ML, Wingard JR.

Biol Blood Marrow Transplant. 2019 Feb;25(2):362-368. doi: 10.1016/j.bbmt.2018.09.031. Epub 2018 Oct 2.

PMID:
30287390
33.

Prof. Franco Mandelli: Leukaemia therapy pioneer.

Gale RP, Lo-Coco F.

Bone Marrow Transplant. 2018 Nov;53(11):1375-1376. doi: 10.1038/s41409-018-0348-5. Epub 2018 Oct 2. No abstract available.

PMID:
30279574
34.

Response to "Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions" by Heidel et al.

Barosi G, Passamonti F, Accorsi P, Pane F, Vannucchi AM, Velati C, Gale RP, Tura S, Barbui T.

Leukemia. 2018 Dec;32(12):2727-2728. doi: 10.1038/s41375-018-0259-x. Epub 2018 Sep 28. No abstract available.

PMID:
30267006
35.

Autotransplantations Without Cryopreservation.

Ruiz-Argüelles GJ, Gale RP.

J Glob Oncol. 2018 Sep;4:1. doi: 10.1200/JGO.18.00021. No abstract available.

36.

Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China?

Yang S, Gale RP, Shi H, Liu Y, Lai Y, Lu J, Huang X.

Leuk Res. 2018 Oct;73:16-20. doi: 10.1016/j.leukres.2018.08.011. Epub 2018 Aug 22.

PMID:
30176386
37.

Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.

Chhabra S, Liu Y, Hemmer MT, Costa L, Pidala JA, Couriel DR, Alousi AM, Majhail NS, Stuart RK, Kim D, Ringden O, Urbano-Ispizua A, Saad A, Savani BN, Cooper B, Marks DI, Socie G, Schouten HC, Schoemans H, Abdel-Azim H, Yared J, Cahn JY, Wagner J, Antin JH, Verdonck LF, Lehmann L, Aljurf MD, MacMillan ML, Litzow MR, Solh MM, Qayed M, Hematti P, Kamble RT, Vij R, Hayashi RJ, Gale RP, Martino R, Seo S, Hashmi SK, Nishihori T, Teshima T, Gergis U, Inamoto Y, Spellman SR, Arora M, Hamilton BK.

Biol Blood Marrow Transplant. 2019 Jan;25(1):73-85. doi: 10.1016/j.bbmt.2018.08.018. Epub 2018 Aug 25.

PMID:
30153491
38.

Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between Groups.

Scott EC, Hari P, Kumar S, Fraser R, Davila O, Shah N, Gale RP, Diaz MA, Agrawal V, Cornell RF, Ganguly S, Akpek G, Freytes C, Hashmi S, Malek E, Kamble RT, Lazarus H, Solh M, Usmani SZ, Kanate AS, Saad A, Chhabra S, Gergis U, Cerny J, Kyle RA, Lee C, Kindwall-Keller T, Assal A, Hildebrandt GC, Holmberg L, Maziarz RT, Nishihori T, Seo S, Kumar S, Mark T, D'Souza A.

Biol Blood Marrow Transplant. 2018 Dec;24(12):2443-2449. doi: 10.1016/j.bbmt.2018.08.013. Epub 2018 Aug 22.

PMID:
30142419
39.

Cancer care in the Palestinian territories.

Halahleh K, Gale RP.

Lancet Oncol. 2018 Jul;19(7):e359-e364. doi: 10.1016/S1470-2045(18)30323-1. Epub 2018 Jun 29. Review.

PMID:
30084383
40.

Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.

Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn JY, D'Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y, Khera N, Kindwall-Keller T, Landau H, Lazarus H, Majhail NS, Marks DI, Olsson RF, Seo S, Steinberg A, William BM, Wirk B, Yared JA, Aljurf M, Abidi MH, Allewelt H, Beitinjaneh A, Cook R, Cornell RF, Fay JW, Hale G, Chakrabarty JH, Jodele S, Kasow KA, Mahindra A, Malone AK, Popat U, Rizzo JD, Schouten HC, Warwick AB, Wood WA, Sekeres MA, Litzow MR, Gale RP, Hashmi SK.

Leuk Res. 2018 Nov;74:130-136. doi: 10.1016/j.leukres.2018.07.016. Epub 2018 Jul 19.

PMID:
30055822
41.

Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera.

Barbui T, Passamonti F, Accorsi P, Pane F, Vannucchi AM, Velati C, Gale RP, Tura S, Barosi G.

Leukemia. 2018 Sep;32(9):2077-2081. doi: 10.1038/s41375-018-0199-5. Epub 2018 Jun 28. No abstract available.

PMID:
29955128
42.

Are We Prepared for Nuclear Terrorism?

Gale RP, Armitage JO.

N Engl J Med. 2018 Jun 21;378(25):2449-2450. doi: 10.1056/NEJMc1805627. No abstract available.

PMID:
29924952
43.

New drugs in AML: uses and abuses.

Estey EH, Gale RP, Sekeres MA.

Leukemia. 2018 Jul;32(7):1479-1481. doi: 10.1038/s41375-018-0168-z. Epub 2018 Jun 6. No abstract available.

PMID:
29875431
44.

Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine.

Harris AC, Boelens JJ, Ahn KW, Fei M, Abraham A, Artz A, Dvorak C, Frangoul H, Freytes C, Gale RP, Hong S, Lazarus HM, Loren A, Mineishi S, Nishihori T, O'Brien T, Williams K, Pasquini MC, Levine JE.

Blood Adv. 2018 Jun 12;2(11):1198-1206. doi: 10.1182/bloodadvances.2018016956.

45.

The prognostic role of HBV infection in chronic lymphocytic leukemia.

Liang JH, Gao R, Dai JC, Gale RP, Li W, Fan L, Hu ZB, Xu W, Li JY.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1309-1315. doi: 10.1007/s00432-018-2663-z. Epub 2018 May 14.

PMID:
29761374
46.

High-dose chemotherapy and autotransplants for plasma cell myeloma in Jordan.

Halahleh K, Ma'koseh M, Abu-Jazar H, Yaser S, Howar H, Al-Rawashdeh M, Tbakhi A, Najjar R, Hussein N, Al-Rimawi D, Gale RP, Sarhan M.

Bone Marrow Transplant. 2018 Oct;53(10):1349-1350. doi: 10.1038/s41409-018-0201-x. Epub 2018 May 8. No abstract available.

PMID:
29740180
47.

Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.

Kumar AJ, Kim S, Hemmer MT, Arora M, Spellman SR, Pidala JA, Couriel DR, Alousi AM, Aljurf MD, Cahn JY, Cairo MS, Cutler CS, Farhan S, Gergis U, Hale GA, Hashmi SK, Inamoto Y, Kamble RT, Kharfan-Dabaja MA, MacMillan ML, Marks DI, Nakasone H, Norkin M, Qayed M, Ringden O, Schouten HC, Schultz KR, Solh MM, Teshima T, Urbano-Ispizua A, Verdonck LF, Gale RP, Hamilton BK, Majhail NS, Loren AW.

Blood Adv. 2018 May 8;2(9):1022-1031. doi: 10.1182/bloodadvances.2017013052. Erratum in: Blood Adv. 2018 Jun 12;2(11):1294.

48.

Introducing Prof. Shaun McCann, Bone Marrow Transplantation's New Sommelier.

Gale RP.

Bone Marrow Transplant. 2018 May;53(5):519-520. doi: 10.1038/s41409-018-0129-1. Epub 2018 May 4. No abstract available.

PMID:
29728696
49.

Chinese and Europeans with acute myeloid leukemia have discordant mutation topographies.

Zhang M, Yin J, He Q, Zhang F, Huang H, Wu B, Wang X, Liu H, Yin H, Zeng Y, Gale RP, Wu D, Yin B.

Leuk Res. 2018 Jul;70:8-12. doi: 10.1016/j.leukres.2018.04.009. Epub 2018 Apr 22.

PMID:
29727824
50.

Study Limitations in HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia.

Gale RP.

JAMA Oncol. 2018 Jun 1;4(6):891. doi: 10.1001/jamaoncol.2018.0364. No abstract available.

PMID:
29710179

Supplemental Content

Loading ...
Support Center